Dana–Farber Cancer Institute
Cancer treatment and research institution in Boston, US / From Wikipedia, the free encyclopedia
Dana-Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Quick Facts Geography, Location ...
Dana-Farber Cancer Institute | |
---|---|
Geography | |
Location | 450 Brookline Avenue, Boston, Massachusetts, United States |
Coordinates | 42.337637°N 71.108195°W / 42.337637; -71.108195 |
Organization | |
Care system | Private |
Funding | Non-profit hospital |
Type | Specialist |
Affiliated university | Harvard Medical School, Harvard University |
Services | |
Standards | NCI-designated Cancer Center |
Speciality | Oncology, Teaching hospital |
Helipad | Yes |
Public transit access | MBTA
|
History | |
Opened | 1947 |
Links | |
Website | www |
Lists | Hospitals in Massachusetts |
Close
As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world.[1] Two Nobel laureates in Physiology or Medicine are among its past and present faculty. Dana-Farber's research discoveries include the development of the highly successful Gleevec to treat chronic myeloid leukemia.